Atlas Trials

Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation.

Clinical trial NCT05720572 · UNKNOWN

Trial details

NCT number
NCT05720572
Sponsor
Centre of Postgraduate Medical Education
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2019-09-01
Primary completion
2025-09-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.